Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study

March 11, 2022 updated by: University of Aarhus

Bioavailability of Anthocyanins From Aronia Extract

In a quadruple cross-over design, 8 healthy men will receive 3 different formulations of Aronia extract as well as placebo (placebo, aronia, and fermented aronia in 1/6 and 1/1 concentration). The intervention will be given on four separate days at least three days apart. Before consumption, 2 fasting blood samples will be taken. Blood will also be sampled at 60, 120, 240, and 360 minutes post consumption. The blood samples will be analyzed for polyphenolic content with a special focus on anthocyanins.

Study Overview

Detailed Description

Methods for possible intervention The trial will be executed in accordance with the guidelines of the declaration of Helsinki and will be approved by The Danish Ethical Committee (1-10-72-57-20). The study is designed as a randomized acute-crossover study repeated on 4 separate days. All participants will be screened, and written consent must be obtained before the initiation of the study. Prior to the first intervention day, participants will be randomized to the order of the intervention; placebo, 1/6 mg or 1/1 fermented aronia extract or non-fermented aronia extract. In order to prevent any cross contamination between intervention days, no less than 3 washout days must pass between intervention days. Participants must be fasting for at least 8 hours with only water allowed.

Participants Participants will be recruited by advertisements as well as social media. Potential candidates will afterwards be referred to the head of the study who will orally explain the study. Provided interest from candidate, a written consent must be obtained. Participants will have the right to end their participation at any given point.

Intervention day and blood collections On intervention days, participants arrive fasting (water allowed since midnight). The intervention will be randomized as to which of the four interventions the participants are going to consume on the day. All participants will consume each intervention of either placebo, 1/6 or 1/1 dose fermented aronia extract or 1/1 dose from non-fermented aronia extract. 15 mins prior to consuming the intervention, a blood sample will be collected. Another sample will be collected at time 0 h, after which time the aronia extract along with 200 mL water must be consumed. Then, at time 60, 120, 240 and 360 min, blood must be collected also. At least 3 washout days must pass between intervention to ensure no cross contamination.

Biochemical analysis Following a successful collection of 6 blood samples over the course of 360 mins on intervention day, the blood from each participant will be stored at -80°C until analysis. The blood samples will be coded in an anonymous way to ensure that blood sample cannot be connected to participant to ensure anonymity. The analysis can be carried out by means of high-pressure liquid chromatography (HPLC) or an equivalent method. The blood samples must be evaluated for their possible anthocyanin content as well as their phenolic compound content.

Statistical analysis Primary outcome is area under the curve (total and incremental) for the response curves of anthocyanins.

To determine differences between groups, ANOVA test will be carried out. Data are considered significant if p < 0.05.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Danmark
      • Aarhus N, Danmark, Denmark, 8200
        • Aarhus University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • man between ≥20 ≤75 years of age

Exclusion Criteria:

  • Daily usage of medicine, alcohol- or substance abuse
  • BMI ≥30

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
The participants are receiving 1 dose of each in the stated order.
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Active Comparator: Fermented aronia high dose
The participants are receiving 1 dose of each in the stated order.
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Active Comparator: Fermented aronia low dose
The participants are receiving 1 dose of each in the stated order.
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Active Comparator: Aronia
The participants are receiving 1 dose of each in the stated order.
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)
Other Names:
  • Chokeberry
Administered once (acute study)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
area under the curve for anthocyanin blood concentration
Time Frame: -15, 0, 60, 120, 240, 360 minutes
Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption
-15, 0, 60, 120, 240, 360 minutes
incremental area under the curve for anthocyanin blood concentration
Time Frame: -15, 0, 60, 120, 240, 360 minutes
Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption
-15, 0, 60, 120, 240, 360 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of polyphenols in the blood
Time Frame: -15, 0, 60, 120, 240, 360 minutes
Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption
-15, 0, 60, 120, 240, 360 minutes
Antioxidant activity in the blood
Time Frame: -15, 0, 60, 120, 240, 360 minutes
Blood is sampled before (-15, 0) and after (60, 120, 240, 360) consumption
-15, 0, 60, 120, 240, 360 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 23, 2020

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

February 1, 2021

Study Registration Dates

First Submitted

November 20, 2020

First Submitted That Met QC Criteria

November 20, 2020

First Posted (Actual)

November 27, 2020

Study Record Updates

Last Update Posted (Actual)

March 28, 2022

Last Update Submitted That Met QC Criteria

March 11, 2022

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1-10-72-57-20

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bioavailability

Clinical Trials on Aronia melanocarpa

3
Subscribe